Stock FRE FRESENIUS SE & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra
Other stock markets
 11:35:07 2024-04-26 am EDT 		5-day change 1st Jan Change
27.21 EUR +0.11% Intraday chart for Fresenius SE & Co. KGaA +1.15% -3.06%
Apr. 26 FRESENIUS SE : Jefferies reiterates its Buy rating ZD
Apr. 24 European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,969 21,095 19,769 14,785 15,810 15,326 - -
Enterprise Value (EV) 1 53,573 45,171 44,160 39,799 15,810 29,598 28,806 26,317
P/E ratio 14.8 x 12.4 x 10.9 x 10.8 x - 10.6 x 8.66 x 8.17 x
Yield 1.67% 2.33% 2.6% 3.5% - 3.43% 3.89% 4.29%
Capitalization / Revenue 0.79 x 0.58 x 0.53 x 0.36 x 0.71 x 0.67 x 0.64 x 0.61 x
EV / Revenue 1.51 x 1.25 x 1.18 x 0.97 x 0.71 x 1.29 x 1.2 x 1.05 x
EV / EBITDA 7.54 x 6.33 x 6.47 x 6.32 x 4.62 x 7.91 x 7.11 x 6.04 x
EV / FCF 49.6 x 18.2 x 37 x 17.4 x - 22 x 19.8 x 16.2 x
FCF Yield 2.02% 5.49% 2.7% 5.73% - 4.55% 5.05% 6.18%
Price to Book 1.67 x 1.24 x 1.04 x 0.72 x - 0.75 x 0.71 x 0.69 x
Nbr of stocks (in thousands) 557,380 557,472 558,454 563,237 563,237 563,237 - -
Reference price 2 50.18 37.84 35.40 26.25 28.07 27.21 27.21 27.21
Announcement Date 2/20/20 2/23/21 2/22/22 3/4/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 35,409 36,277 37,520 40,840 22,299 22,959 24,060 25,178
EBITDA 1 7,104 7,132 6,825 6,294 3,422 3,742 4,051 4,355
EBIT 1 4,599 4,612 4,252 4,004 2,262 2,449 2,740 2,982
Operating Margin 12.99% 12.71% 11.33% 9.8% 10.14% 10.67% 11.39% 11.84%
Earnings before Tax (EBT) 1 3,912 3,726 3,652 2,814 - 2,058 2,270 2,477
Net income 1 1,883 1,707 1,818 1,372 - 1,424 1,758 1,849
Net margin 5.32% 4.71% 4.85% 3.36% - 6.2% 7.31% 7.34%
EPS 2 3.380 3.060 3.260 2.440 - 2.563 3.143 3.332
Free Cash Flow 1 1,081 2,478 1,193 2,281 - 1,346 1,455 1,628
FCF margin 3.05% 6.83% 3.18% 5.59% - 5.86% 6.05% 6.46%
FCF Conversion (EBITDA) 15.22% 34.74% 17.48% 36.24% - 35.97% 35.92% 37.37%
FCF Conversion (Net income) 57.41% 145.17% 65.62% 166.25% - 94.56% 82.76% 88.03%
Dividend per Share 2 0.8400 0.8800 0.9200 0.9200 - 0.9328 1.060 1.167
Announcement Date 2/20/20 2/23/21 2/22/22 3/4/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 18,055 18,230 9,324 9,966 9,720 10,018 10,459 10,643 10,225 10,359 5,518 5,678 5,703 5,778 5,720 5,863 -
EBITDA 1 - - 1,667 1,868 1,658 - 1,658 - 1,585 1,649 - - 633.7 - - - -
EBIT 1 2,248 2,039 1,041 1,166 996 1,003 949 1,052 908 956 519 634 621 635.6 601.9 630.1 -
Operating Margin 12.45% 11.18% 11.16% 11.7% 10.25% 10.01% 9.07% 9.88% 8.88% 9.23% 9.41% 11.17% 10.89% 11% 10.52% 10.75% -
Earnings before Tax (EBT) - - 882 1,001 784 729 551 - - - - - - - - - -
Net income 1 - 906 413 499 413 383 321 255 346 80 -406 - 288.3 297.1 283.5 200.3 -
Net margin - 4.97% 4.43% 5.01% 4.25% 3.82% 3.07% 2.4% 3.38% 0.77% -7.36% - 5.06% 5.14% 4.96% 3.42% -
EPS 2 1.560 1.620 0.7400 0.9000 0.7400 0.6800 0.5700 0.4500 0.6100 0.1500 -0.7200 - 0.6248 0.6526 0.5011 0.3541 -
Dividend per Share 2 - - - 0.9200 - - - 0.9200 - - - - - - - 0.9200 -
Announcement Date 7/30/20 7/30/21 11/2/21 2/22/22 5/4/22 8/2/22 11/1/22 3/4/23 5/9/23 8/2/23 11/2/23 2/21/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 25,604 24,076 24,391 25,014 - 14,272 13,480 10,991
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.604 x 3.376 x 3.574 x 3.974 x - 3.814 x 3.328 x 2.524 x
Free Cash Flow 1 1,081 2,478 1,193 2,281 - 1,346 1,455 1,628
ROE (net income / shareholders' equity) 11.3% 10.1% 10.1% 8.5% - 7.77% 8.26% 8.37%
ROA (Net income/ Total Assets) 3.19% 2.55% 2.62% 2.33% - 2.55% 2.94% 3.56%
Assets 1 58,973 66,826 69,305 58,871 - 55,867 59,853 51,866
Book Value Per Share 2 30.10 30.40 34.00 36.20 - 36.50 38.60 39.30
Cash Flow per Share 2 6.310 11.70 9.100 7.480 - 4.420 4.850 5.350
Capex 1 2,433 2,366 2,017 1,917 - 1,197 1,254 1,310
Capex / Sales 6.87% 6.52% 5.38% 4.69% - 5.22% 5.21% 5.2%
Announcement Date 2/20/20 2/23/21 2/22/22 3/4/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.21 EUR
Average target price
36.28 EUR
Spread / Average Target
+33.34%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. FRE Stock
  4. Financials Fresenius SE & Co. KGaA